{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:03:36Z","timestamp":1780401816665,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.ophtha.2004.08.022","type":"journal-article","created":{"date-parts":[[2005,1,8]],"date-time":"2005-01-08T22:16:51Z","timestamp":1105222611000},"page":"262-266","source":"Crossref","is-referenced-by-count":79,"title":["Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients"],"prefix":"10.1016","volume":"112","author":[{"given":"Anastasios G.P.","family":"Konstas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Katsimbris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Lallos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George P.","family":"Boukaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2004.08.022_bib1","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0161-6420(95)30798-1","article-title":"Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning: a comparison with timolol","volume":"102","author":"Alm","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2004.08.022_bib2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0161-6420(96)30749-5","article-title":"Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month, masked, multicenter trial in the United States","volume":"103","author":"Camras","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2004.08.022_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0161-6420(96)30750-1","article-title":"A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension","volume":"103","author":"Watson","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2004.08.022_bib4","unstructured":"Stewart WC. Influence on the diurnal curve of the intraocular pressure with current ocular hypotensive. Rev Ophthalmol 2001 Nov;128\u201332."},{"issue":"suppl","key":"10.1016\/j.ophtha.2004.08.022_bib5","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0039-6257(02)00323-5","article-title":"The hydrolysis of bimatoprost in corneal tissue generates a potent prostanoid FP receptor agonist","volume":"47","author":"Maxey","year":"2002","journal-title":"Surv Ophthalmol"},{"issue":"suppl","key":"10.1016\/j.ophtha.2004.08.022_bib6","doi-asserted-by":"crossref","first-page":"S337","DOI":"10.1016\/S0039-6257(01)00224-7","article-title":"The pharmacology of bimatoprost (Lumigan)","volume":"45","author":"Woodward","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.08.022_bib7","doi-asserted-by":"crossref","first-page":"S361","DOI":"10.1016\/S0039-6257(01)00219-3","article-title":"Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure","volume":"45","author":"Sherwood","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.08.022_bib8","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archopht.119.7.994","article-title":"Comparison of the ocular hypotensive lipid AGN 192024 with timolol: dosing, efficacy, and safety evaluation of a novel compound for glaucoma management","volume":"119","author":"Laibovitz","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"suppl","key":"10.1016\/j.ophtha.2004.08.022_bib9","doi-asserted-by":"crossref","first-page":"S353","DOI":"10.1016\/S0039-6257(01)00212-0","article-title":"Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost","volume":"45","author":"DuBiner","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.08.022_bib10","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0002-9394(00)00930-2","article-title":"Washout periods for brimonidine 0.2% and latanoprost 0.005%","volume":"131","author":"Stewart","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.08.022_bib11","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0161-6420(03)00404-4","article-title":"Twenty-four-hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination","volume":"110","author":"Konstas","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2004.08.022_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/sj.eye.6700257","article-title":"The efficacy and safety of the timolol\/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma","volume":"17","author":"Konstas","year":"2003","journal-title":"Eye"},{"key":"10.1016\/j.ophtha.2004.08.022_bib13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0002-9394(02)01460-5","article-title":"A comparison of once-daily morning vs evening dosing of concomitant latanoprost\/timolol","volume":"133","author":"Konstas","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.08.022_bib14","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0002-9394(01)00834-0","article-title":"Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma","volume":"131","author":"Konstas","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.08.022_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/eye.2001.14","article-title":"Twenty-four hour intraocular pressure reduction with latanoprost compared with pilocarpine as third-line therapy in exfoliation glaucoma","volume":"15","author":"Konstas","year":"2001","journal-title":"Eye"},{"key":"10.1016\/j.ophtha.2004.08.022_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/eye.2000.16","article-title":"Twenty-four hour control of intraocular pressure with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma","volume":"14","author":"Konstas","year":"2000","journal-title":"Eye"},{"key":"10.1016\/j.ophtha.2004.08.022_bib17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/archopht.121.4.453","article-title":"Effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension","volume":"121","author":"Orzalesi","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.08.022_bib18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archopht.1997.01100150184006","article-title":"Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma","volume":"115","author":"Konstas","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.08.022_bib19","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/archopht.1997.01100160145002","article-title":"Effect of timolol on the diurnal intraocular pressure in exfoliation and primary open-angle glaucoma","volume":"115","author":"Konstas","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.08.022_bib20","series-title":"Essentials of Statistics","author":"Book","year":"1978"},{"key":"10.1016\/j.ophtha.2004.08.022_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/jop.1998.14.129","article-title":"The safety and efficacy of switching timolol maleate 0.5% solution to timolol hemihydrate 0.5% solution given twice daily","volume":"14","author":"Mundorf","year":"1998","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2004.08.022_bib22","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1755-3768.1987.tb07052.x","article-title":"A double-masked crossover study comparing the effects of carteolol 1% and 2% on intra-ocular pressure","volume":"65","author":"Duff","year":"1987","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.ophtha.2004.08.022_bib23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0002-9394(00)00902-8","article-title":"The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension","volume":"131","author":"Stewart","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.08.022_bib24","series-title":"Nonparametric Statistics for the Behavioral Sciences","author":"Siegel","year":"1956"},{"key":"10.1016\/j.ophtha.2004.08.022_bib25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF02850299","article-title":"Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension","volume":"18","author":"Gandolfi","year":"2001","journal-title":"Adv Ther"},{"key":"10.1016\/j.ophtha.2004.08.022_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0002-9394(02)01827-5","article-title":"A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma","volume":"135","author":"Noecker","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.08.022_bib27","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0002-9394(03)00098-9","article-title":"A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study","volume":"135","author":"Parrish","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.08.022_bib28","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00061198-200004000-00002","article-title":"Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma","volume":"9","author":"Asrani","year":"2000","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2004.08.022_bib29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0161-6420(91)32340-6","article-title":"Association between intraocular pressure peaks and progression of visual field loss","volume":"98","author":"Zeimer","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2004.08.022_bib30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0002-9394(14)71282-6","article-title":"Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head","volume":"116","author":"Stewart","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.08.022_bib31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00061198-200306000-00009","article-title":"24-hour monitoring of intraocular pressure in glaucoma management: a retrospective review","volume":"12","author":"Hughes","year":"2003","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2004.08.022_bib32","unstructured":"Stewart WC. Maximizing medical therapy for glaucoma. Rev Ophthalmol 2002 Feb;39\u201345."},{"key":"10.1016\/j.ophtha.2004.08.022_bib33","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0002-9394(02)01980-3","article-title":"Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost","volume":"135","author":"Stewart","year":"2003","journal-title":"Am J Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642004014691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642004014691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T05:22:25Z","timestamp":1548825745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642004014691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0161642004014691"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2004.08.022","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}